313 related articles for article (PubMed ID: 29273559)
1. High specificity of spot urinary free metanephrines in diagnosis and prognosis of pheochromocytomas and paragangliomas by HPLC with electrochemical detection.
Zuo M; Zhen Q; Zhang X; Zou W; Yang X; Tian G; Shi Z; Li Q; Ding M
Clin Chim Acta; 2018 Mar; 478():82-89. PubMed ID: 29273559
[TBL] [Abstract][Full Text] [Related]
2. Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas.
Wang H; Zhang X; Zhen Q; Zou W; Chen H; Luo C; Ding M
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122306. PubMed ID: 32829134
[TBL] [Abstract][Full Text] [Related]
3. Dual-Template Magnetic Molecularly Imprinted Polymer for Simultaneous Determination of Spot Urine Metanephrines and 3-Methoxytyramine for the Diagnosis of Pheochromocytomas and Paragangliomas.
Zeng H; Zhang X; Zhen Q; He Y; Wang H; Zhu Y; Sun Q; Ding M
Molecules; 2022 May; 27(11):. PubMed ID: 35684457
[TBL] [Abstract][Full Text] [Related]
4. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
[TBL] [Abstract][Full Text] [Related]
5. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
[TBL] [Abstract][Full Text] [Related]
6. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
Bokuda K; Yatabe M; Seki Y; Ichihara A
Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
[TBL] [Abstract][Full Text] [Related]
7. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
[TBL] [Abstract][Full Text] [Related]
8. Random 'spot' urinary metanephrines compared with 24-h-urinary and plasma results in phaeochromocytomas and paragangliomas.
Sbardella E; Maunsell Z; May CJH; Tadman M; James T; Jafar-Mohammadi B; Isidori AM; Grossman AB; Shine B
Eur J Endocrinol; 2020 Aug; 183(2):129-139. PubMed ID: 32413848
[TBL] [Abstract][Full Text] [Related]
9. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma.
Ito Y; Obara T; Okamoto T; Kanbe M; Tanaka R; Iihara M; Okamoto J; Yamazaki K; Jibiki K
World J Surg; 1998 Jul; 22(7):684-8. PubMed ID: 9606282
[TBL] [Abstract][Full Text] [Related]
11. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of free plasma metanephrines for the diagnosis of catecholamine-producing tumors.
Pussard E; Chaouch A; Said T
Clin Chem Lab Med; 2014 Mar; 52(3):437-44. PubMed ID: 24088613
[TBL] [Abstract][Full Text] [Related]
13. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
de Jong WH; Eisenhofer G; Post WJ; Muskiet FA; de Vries EG; Kema IP
J Clin Endocrinol Metab; 2009 Aug; 94(8):2841-9. PubMed ID: 19567530
[TBL] [Abstract][Full Text] [Related]
14. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.
Därr R; Kuhn M; Bode C; Bornstein SR; Pacak K; Lenders JWM; Eisenhofer G
Endocrine; 2017 Jun; 56(3):495-503. PubMed ID: 28405881
[TBL] [Abstract][Full Text] [Related]
16. Plasma and urinary metanephrine and normetanephrine concentrations using liquid chromatography with tandem mass spectrometry in healthy cats and in a cat with pheochromocytoma.
Prego MT; Dias MJ; Ferreira RL; Gonçalves S; Dias Domingues T; Junius G; Van den Steen E; Galac S; Leal RO
J Vet Intern Med; 2023; 37(3):910-914. PubMed ID: 37057306
[TBL] [Abstract][Full Text] [Related]
17. Measurements of plasma metanephrines by immunoassay vs liquid chromatography with tandem mass spectrometry for diagnosis of pheochromocytoma.
Weismann D; Peitzsch M; Raida A; Prejbisz A; Gosk M; Riester A; Willenberg HS; Klemm R; Manz G; Deutschbein T; Kroiss M; Därr R; Bidlingmaier M; Januszewicz A; Eisenhofer G; Fassnacht M
Eur J Endocrinol; 2015 Mar; 172(3):251-60. PubMed ID: 25452465
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
19. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
[TBL] [Abstract][Full Text] [Related]
20. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
